UK Companies House feature
BARD PHARMACEUTICALS LIMITED
Profile
- Company number
- 00987562
- Status
- Active
- Incorporation
- 1970-08-21
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on this assessment the directors continue to adopt the going concern basis in preparing the annual report and accounts. In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.”
Significant events
- “Capital expenditure has increased by £5,202,000 (75%) compared to the comparative figures for 2023. This is due to the ongoing investment program to expand the existing Good Manufacturing Practice (GMP) filling and packaging area, replacing obsolete equipment & control systems and modernising the IT systems used in the manufacturing operation.”
- “On 16 June 2023, a UK High Court judgment in the case of Virgin Media Ltd v NTL Pension Trustees II Ltd raised questions regarding the validity of certain amendments made to contracted-out defined benefit (DB) pension schemes between 1997 and 2016. In July 2024, the Court of Appeal dismissed the appeal brought by Virgin Media Ltd against aspects of the June 2023 decision.”
- “The Company's pension scheme was contracted out during this period and made amendments that may have affected members' benefits. A legal review in 2024 concluded that all significant amendments made between 1997 and 2016 were accompanied by the necessary actuarial confirmation.”
- “On 5 June 2025, the Department for Work and Pensions announced it will introduce legislation to allow defined benefit pensions schemes to obtain retrospective sign-off on historic actuarial amendments. The industry is awaiting the details of this legislation and the outcome of a secondary High Court case to clarify what next steps are required.”
- “There have been no subsequent events affecting the Company since the year end.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JAMIESON, Stephen Johan | Director | 2019-02-22 | Sep 1957 | British |
| LEA, Bryan George | Director | 2020-01-01 | Jun 1961 | British |
| VARSHNEY, Ajay | Director | 2024-06-14 | May 1974 | Indian |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CORNHILL SERVICES LIMITED | Corporate Secretary | 2008-03-25 | 2009-02-26 |
| TIERCEL SERVICES LIMITED | Corporate Secretary | 2009-02-26 | 2018-06-11 |
| TIERCEL SERVICES LIMITED | Corporate Secretary | — | 2008-03-25 |
| BAKER, Stuart David | Director | 2017-08-08 | 2019-12-31 |
| BRADLEY, Dominic Michael, Dr | Director | 2023-02-03 | 2024-12-13 |
| BROGDEN, John Robert | Director | — | 2005-03-30 |
| CHAPLIN, John Richard | Director | — | 1999-09-09 |
| CLARKE, Robert Alan | Director | 2012-11-07 | 2015-12-31 |
| GOFF, Valerie May | Director | 1999-01-31 | 2015-12-31 |
| LESLIE, Stewart T | Director | — | 1997-12-31 |
| MANNERS, Paul | Director | — | 2001-12-31 |
| MATTESSICH, Antony Charles | Director | 2005-04-01 | 2017-07-31 |
| MITCHELL, Christopher Benbow | Director | — | 2018-04-12 |
| MOODY, Colm Joseph | Director | 2015-04-01 | 2022-06-30 |
| NICOL, Eric Gordan | Director | — | 1999-12-31 |
| WIKSTROM, Ake Gunnar | Director | 2018-04-12 | 2019-02-22 |
| WIKSTROM, Ake Gunnar | Director | 2001-09-05 | 2011-05-19 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Napp Pharmaceutical Group Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 168 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-11-17 | CH01 | officers | change person director company with change date |
| 2025-09-09 | AA | accounts | accounts with accounts type full |
| 2025-05-29 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-02-06 | AD02 | address | change sail address company with old address new address |
| 2024-12-13 | TM01 | officers | termination director company with name termination date |
| 2024-12-12 | MR04 | mortgage | mortgage satisfy charge full |
| 2024-12-12 | MR04 | mortgage | mortgage satisfy charge full |
| 2024-12-12 | MR04 | mortgage | mortgage satisfy charge full |
| 2024-08-27 | AA | accounts | accounts with accounts type full |
| 2024-06-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-06-14 | AP01 | officers | appoint person director company with name date |
| 2024-04-04 | CH01 | officers | change person director company with change date |
| 2023-10-12 | AA | accounts | accounts with accounts type full |
| 2023-06-15 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-02-13 | AP01 | officers | appoint person director company with name date |
| 2022-12-14 | AA | accounts | accounts with accounts type full |
| 2022-07-26 | AD01 | address | change registered office address company with date old address new address |
| 2022-07-04 | CH01 | officers | change person director company with change date |
| 2022-07-04 | TM01 | officers | termination director company with name termination date |
| 2022-06-22 | AD02 | address | change sail address company with old address new address |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory